REG - Surgical Innovations - Result of Equity Issue <Origin Href="QuoteRef">SUNU.L</Origin>

Surgical InnovationsAnnouncement

27/07/2017 10:55

RNS Number : 2873M
Surgical Innovations Group PLC
27 July 2017
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Surgical Innovations Group plc
Result of the Placing, Directors' Participation and Related Party Transaction
Further to the accelerated bookbuilding process and proposed Acquisition of Elemental Healthcare Limited announced earlier today, the Company is pleased to announce that the Vendor Placing and the Subscriptions have, in aggregate, conditionally raised gross proceeds of approximately 5.5 million through the issue of 183,333,333 New Ordinary Shares at a price of 3p per share.
Directors' Participation
Certain of the Directors have conditionally subscribed for New Ordinary Shares as follows:
Director
Number of New Ordinary Shares subscribed for
Holding of Ordinary Shares following Admission
% of Enlarged Issued Share Capital following Admission




Nigel Rogers
710,385
4,403,863
0.56
Melanie Ross
333,333
1,573,710
0.20
Paul Hardy
1,538,990
5,914,464
0.76
Mike McMahon
166,666
18,504,737
2.37
Related Party Transaction
Getz Bros. & Co. (BVI) Limited, which is a substantial shareholder in the Company as defined in the AIM Rules, has conditionally agreed to subscribe for 20,296,706 New Ordinary Shares (the "Getz Subscription"). The Getz Subscription constitutes a related party transaction for the purposes of the AIM Rules. Alistair Taylor, the Director who has not conditionally subscribed for New Ordinary Shares, having consulted with WH Ireland, the Company's nominated adviser, considers that the terms of the Getz Subscription are fair and reasonable insofar as Shareholders are concerned.
Application has been made to the London Stock Exchange for admission to trading of the New Ordinary Shares on AIM. It is expected that Admission will take place and dealings in the New Ordinary Shares will commence at 8.00 a.m. on 1 August 2017 at which time the Vendor Placing, the Subscriptions and the Acquisition will become unconditional.
The New Ordinary Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive all dividends or other distributions made, paid or declared in respect of such shares after Admission.
Following Admission and the issue of the New Ordinary Shares, there will be 780,264,588 Ordinary Shares in issue.
Capitalised terms used but not defined in this announcement shall have the meanings defined in the announcement issued earlier today.
This Announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Contact details:
Surgical Innovations Group Plc
www.sigroupplc.com
Nigel Rogers, Executive Chairman
Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker)
Tel: 020 7220 1666
Tim Feather (Corporate Finance)
David Kilbourn (Corporate Broking)
Walbrook PR (Financial PR & Investor Relations)
Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus
Mob: 07980 541893
Lianne Cawthorne
Mob: 07584 391303

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ROIOKODPCBKKDOB